- Angular cheilitis treatments, encompassing antifungal, antibacterial, and anti-inflammatory therapies, are increasingly vital in dermatological and primary care settings due to their effectiveness in alleviating painful inflammation and cracks at the corners of the mouth, often caused by fungal or bacterial infections, nutritional deficiencies, or immune disorders
- The escalating demand for angular cheilitis treatment is primarily fueled by growing public awareness of oral and dermatological health, an increase in at-risk populations including diabetics and the elderly, and the rising availability of over-the-counter and prescription-based topical medications.
- North America dominated the angular cheilitis treatment market with the largest revenue share of 38.5% in 2024, characterized by strong healthcare infrastructure, higher diagnostic rates, and widespread consumer access to dermatological care, with the U.S. experiencing substantial treatment uptake driven by proactive skincare habits and increased self-medication through pharmacy-based solutions
- Asia-Pacific is expected to be the fastest growing region in the angular cheilitis treatment market during the forecast period due to expanding healthcare access, growing awareness of personal hygiene, and rising consumer expenditure on OTC treatments
- The antifungal segment dominated the angular cheilitis treatment market with a market share of 45.5% in 2024, driven by its proven efficacy, fast symptom relief, and ease of application, especially in fungal-dominant infections
